LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 95 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,180,271 | -52.2% | 1,483,178 | +3.4% | 0.00% | -100.0% |
Q2 2023 | $4,560,944 | +11.7% | 1,434,259 | -17.1% | 0.00% | 0.0% |
Q1 2023 | $4,084,631 | -46.2% | 1,730,776 | -20.9% | 0.00% | -50.0% |
Q4 2022 | $7,594,230 | -49.2% | 2,188,539 | +7.3% | 0.00% | -33.3% |
Q3 2022 | $14,943,000 | +90.3% | 2,038,717 | +69.3% | 0.00% | +50.0% |
Q2 2022 | $7,852,000 | +47.7% | 1,204,272 | +14.4% | 0.00% | +100.0% |
Q1 2022 | $5,315,000 | +224.5% | 1,052,410 | +397.4% | 0.00% | – |
Q4 2021 | $1,638,000 | -48.2% | 211,577 | -1.1% | 0.00% | -100.0% |
Q3 2021 | $3,165,000 | – | 213,844 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
Artal Group S.A. | 700,000 | $2,429 | 0.14% |
Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |